Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aki Furusawa

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Cancer Science|June 20, 2022
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancerHiroshi Fukushima, Takuya Kato, Aki Furusawa, et al.
Vaccines|September 17, 2020
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer ModelsYasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, et al.
Cancer Immunology Research|September 28, 2022
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade TherapyHiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2022
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancersHiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, et al.
Cancers|August 26, 2022
Optimal Light Dose for hEGFR-Targeted Near-Infrared PhotoimmunotherapyHideyuki Furumoto, Ryuhei Okada, Takuya Kato, et al.
Cancer Science|April 27, 2024
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironmentFuyuki F Inagaki, Makoto Kano, Aki Furusawa, et al.
Cancer Letters|January 25, 2024
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancerHiroshi Fukushima, Seiichiro Takao, Aki Furusawa, et al.
Nanomedicine (London, England)|May 31, 2023
Simultaneous multicolor imaging of lymph node chains using hydroporphyrin-doped near-infrared-emitting polymer dotsTakuya Kato, Connor Riahin, Aki Furusawa, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignanciesSeiichiro Takao, Hiroshi Fukushima, Aki Furusawa, et al.
Cancer Science|April 17, 2025
Impact of Vitamin C on Immune Response and Edema Following Near-Infrared Photoimmunotherapy (NIR-PIT)Hiroshi Yamamoto, Aki Furusawa, Hiroshi Fukushima, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancer Science|June 20, 2022
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancerHiroshi Fukushima, Takuya Kato, Aki Furusawa, et al.
Vaccines|September 17, 2020
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer ModelsYasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, et al.
Cancer Immunology Research|September 28, 2022
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade TherapyHiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2022
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancersHiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, et al.
Cancers|August 26, 2022
Optimal Light Dose for hEGFR-Targeted Near-Infrared PhotoimmunotherapyHideyuki Furumoto, Ryuhei Okada, Takuya Kato, et al.
Cancer Science|April 27, 2024
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironmentFuyuki F Inagaki, Makoto Kano, Aki Furusawa, et al.
Cancer Letters|January 25, 2024
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancerHiroshi Fukushima, Seiichiro Takao, Aki Furusawa, et al.
Nanomedicine (London, England)|May 31, 2023
Simultaneous multicolor imaging of lymph node chains using hydroporphyrin-doped near-infrared-emitting polymer dotsTakuya Kato, Connor Riahin, Aki Furusawa, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignanciesSeiichiro Takao, Hiroshi Fukushima, Aki Furusawa, et al.
Cancer Science|April 17, 2025
Impact of Vitamin C on Immune Response and Edema Following Near-Infrared Photoimmunotherapy (NIR-PIT)Hiroshi Yamamoto, Aki Furusawa, Hiroshi Fukushima, et al.
Pageof 7